Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ADUS NASDAQ:CELC NASDAQ:LFST NASDAQ:SHCR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADUSAddus HomeCare$115.17-0.1%$112.06$88.96▼$136.72$2.13B0.8196,587 shs72,791 shsCELCCelcuity$51.23-6.2%$30.13$7.57▼$55.44$2.32B0.681.13 million shs731,213 shsLFSTLifeStance Health Group$5.48$4.72$3.74▼$8.61$2.13B1.133.22 million shs2.07 million shsSHCRSharecare$1.43$1.43$0.48▼$1.44$531.79M0.512.55 million shsN/AThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADUSAddus HomeCare-0.13%-2.74%+6.76%+2.55%-12.84%CELCCelcuity-6.17%-2.27%+27.12%+380.13%+208.80%LFSTLifeStance Health Group0.00%-1.26%+29.55%-7.90%-12.18%SHCRSharecare0.00%0.00%0.00%0.00%+2.88%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationADUSAddus HomeCare4.9226 of 5 stars3.53.00.05.03.52.53.1CELCCelcuity1.7559 of 5 stars2.52.00.00.02.93.30.0LFSTLifeStance Health Group3.338 of 5 stars3.44.00.00.03.52.50.6SHCRSharecareN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceADUSAddus HomeCare 3.00Buy$138.3820.15% UpsideCELCCelcuity 3.00Buy$56.5010.29% UpsideLFSTLifeStance Health Group 2.86Moderate Buy$8.5055.11% UpsideSHCRSharecare 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest SHCR, ADUS, LFST, and CELC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/22/2025ADUSAddus HomeCareRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$133.00 ➝ $134.008/19/2025ADUSAddus HomeCareBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetUnderweight ➝ Underweight$83.00 ➝ $109.008/18/2025CELCCelcuityHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$50.00 ➝ $66.008/15/2025CELCCelcuityNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$74.00 ➝ $70.008/8/2025LFSTLifeStance Health GroupUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$8.50 ➝ $9.008/6/2025ADUSAddus HomeCareTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$135.00 ➝ $139.007/28/2025CELCCelcuityLeerink PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$28.00 ➝ $60.007/28/2025CELCCelcuityHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$27.00 ➝ $50.007/28/2025CELCCelcuityNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$29.007/25/2025LFSTLifeStance Health GroupBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$8.007/16/2025ADUSAddus HomeCareJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$150.00(Data available from 8/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookADUSAddus HomeCare$1.15B1.84$5.38 per share21.40$55.44 per share2.08CELCCelcuityN/AN/AN/AN/A$1.05 per shareN/ALFSTLifeStance Health Group$1.25B1.70$0.04 per share138.20$3.79 per share1.45SHCRSharecare$445.25M1.19N/AN/A$1.22 per share1.17Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateADUSAddus HomeCare$73.60M$4.5325.4221.491.766.51%9.39%6.86%11/3/2025 (Estimated)CELCCelcuity-$111.78M-$3.45N/AN/AN/AN/A-150.07%-64.67%11/13/2025 (Estimated)LFSTLifeStance Health Group-$57.44M-$0.05N/AN/AN/A-1.23%-1.11%-0.76%11/6/2025 (Estimated)SHCRSharecare-$128.50M-$0.39N/AN/AN/A-33.64%-22.81%-15.96%N/ALatest SHCR, ADUS, LFST, and CELC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q2 2025CELCCelcuity-$0.90-$1.04-$0.14-$1.04N/AN/A8/7/2025Q2 2025LFSTLifeStance Health Group-$0.03-$0.01+$0.02-$0.01$345.05 million$345.31 million8/4/2025Q2 2025ADUSAddus HomeCare$1.45$1.49+$0.04$1.20$345.71 million$349.44 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthADUSAddus HomeCareN/AN/AN/AN/AN/ACELCCelcuityN/AN/AN/AN/AN/ALFSTLifeStance Health GroupN/AN/AN/AN/AN/ASHCRSharecareN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioADUSAddus HomeCare0.171.741.74CELCCelcuity2.244.584.58LFSTLifeStance Health Group0.191.481.48SHCRSharecareN/A2.022.02Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipADUSAddus HomeCare95.35%CELCCelcuity63.33%LFSTLifeStance Health Group85.50%SHCRSharecare35.08%Insider OwnershipCompanyInsider OwnershipADUSAddus HomeCare4.50%CELCCelcuity15.77%LFSTLifeStance Health Group3.20%SHCRSharecare30.61%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableADUSAddus HomeCare49,70318.43 million17.58 millionOptionableCELCCelcuity4042.43 million35.74 millionOptionableLFSTLifeStance Health Group10,218388.94 million376.49 millionOptionableSHCRSharecare3,352371.88 million258.05 millionOptionableSHCR, ADUS, LFST, and CELC HeadlinesRecent News About These CompaniesSharecare to collaborate with Centers for Medicare & Medicaid Services to improve care quality, accelerate progress in healthcareJuly 30, 2025 | globenewswire.comSharecare introduces Condition Masterclass to support patient education and health literacy for chronic disease managementJuly 21, 2025 | globenewswire.comSharecare wins 21 Digital Health Awards in Spring 2025 competitionJune 23, 2025 | globenewswire.comBronstein, Gewirtz & Grossman, LLC Encourages Sharecare Inc. (SHCR) Investors to Inquire about Securities InvestigationJune 17, 2025 | accessnewswire.comABronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sharecare Inc. (SHCR) And Encourages Investors to Reach OutJune 15, 2025 | accessnewswire.comABronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sharecare Inc. (SHCR) And Encourages Stockholders to Reach OutJune 12, 2025 | accessnewswire.comABronstein, Gewirtz & Grossman, LLC Is Investigating Sharecare Inc. (SHCR) And Encourages Stockholders to ConnectJune 10, 2025 | accessnewswire.comABronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sharecare Inc. (SHCR) and Encourages Shareholders to Learn More About the InvestigationJune 8, 2025 | accessnewswire.comASharecare Inc. (SHCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the InvestigationJune 5, 2025 | accessnewswire.comABronstein, Gewirtz & Grossman, LLC Encourages Sharecare Inc. (SHCR) Shareholders to Inquire about Securities InvestigationJune 3, 2025 | accessnewswire.comABronstein, Gewirtz & Grossman, LLC Is Investigating Sharecare Inc. (SHCR) And Encourages Shareholders to ConnectJune 1, 2025 | accessnewswire.comABronstein, Gewirtz & Grossman, LLC Is Investigating Sharecare Inc. (SHCR) And Encourages Investors to ConnectMay 29, 2025 | accessnewswire.comABronstein, Gewirtz & Grossman, LLC Encourages Sharecare Inc. (SHCR) Stockholders to Inquire about Securities InvestigationMay 27, 2025 | accessnewswire.comABronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sharecare Inc. (SHCR) and Encourages Investors to Learn More About the InvestigationMay 25, 2025 | accessnewswire.comASharecare Inc. (SHCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the InvestigationMay 22, 2025 | accessnewswire.comABronstein, Gewirtz & Grossman, LLC Is Investigating Sharecare Inc. (SHCR) And Encourages Investors to ConnectMay 20, 2025 | accessnewswire.comABronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sharecare Inc. (SHCR) and Encourages Stockholders to Learn More About the InvestigationMay 18, 2025 | accessnewswire.comABronstein, Gewirtz & Grossman, LLC Encourages Sharecare Inc. (SHCR) Investors to Inquire about Securities InvestigationMay 15, 2025 | accessnewswire.comABronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sharecare Inc. (SHCR) And Encourages Investors to Reach OutMay 13, 2025 | accessnewswire.comABronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sharecare Inc. (SHCR) And Encourages Stockholders to Reach OutMay 11, 2025 | accessnewswire.comANew MarketBeat Followers Over TimeMedia Sentiment Over TimeSHCR, ADUS, LFST, and CELC Company DescriptionsAddus HomeCare NASDAQ:ADUS$115.17 -0.15 (-0.13%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$115.18 +0.02 (+0.01%) As of 08/29/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.Celcuity NASDAQ:CELC$51.23 -3.37 (-6.17%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$52.00 +0.77 (+1.50%) As of 08/29/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Celcuity Inc., a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, advanced or metastatic breast cancer, and metastatic castration resistant prostate cancer. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. The company was founded in 2011 and is headquartered in Minneapolis, Minnesota.LifeStance Health Group NASDAQ:LFST$5.48 0.00 (0.00%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$5.50 +0.02 (+0.46%) As of 08/29/2025 07:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.Sharecare NASDAQ:SHCRSharecare, Inc. operates as a digital healthcare platform company. Its Sharecare platform connects people, patients, providers, employers, health plans, government organizations, and communities that optimize individual and population-wide well-being. The company offers enterprise solutions based on a software-as-a-service model that allows enterprise clients to message, motivate, and manage their populations, as well as measure their population progress; a suite of data and information-driven solutions; and life sciences solutions, which provides members with personalized information, programs, and resources to improve their health and well-being. It also operates RealAge, a platform for health assessment to assess behaviors and existing conditions of its members and provide metric for their physical health. In addition, the company provides secure, automated release of information, audit, and business consulting services to streamline the medical records process for medical facilities. It sells its solutions through direct sales organization and partner relationships. Sharecare, Inc. was founded in 2009 and is headquartered in Atlanta, Georgia. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Ollie’s Bargain Outlet: Buy it While It’s Still a Bargain Best Buy Marketplace: Potential Growth Catalyst or Risky Gimmick? CrowdStrike at a Crossroads: AI Halo vs. Risks Snowflake’s Snowballing Business and Robust Stock Price Outlook NVIDIA's Earnings Show a Green Light for Taiwan Semiconductor NVIDIA Stock Could Pull Back in September, But Don’t Bet on It 3 Reasons Gartner Could Be the Best Buy of Q3 NIO Just Got Its Second Upgrade of the Month, and It’s Big Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
